Source: Annual Congress 2010 - COPD: management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Farkhutdinov, U. Farkhutdinov (Ufa, Russian Federation). Immunomodulatory efficacy of inferon in chronic obstructive pulmonary disease. Eur Respir J 2010; 36: Suppl. 54, 4004

Member's Comments

No comment yet.

Related content which might interest you: Inferon efficacy in the treatment of chronic obstructive pulmonary disease Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 The results of inferon administration in the treatment of chronic obstructive pulmonary disease Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012 Fenspiride efficacy in the treatment of chronic obstructive pulmonary disease Source: International Congress 2017 – Novel mechanisms and treatments for COPD Year: 2017 Efficacy of lasolvan in the treatment of patients with chronic obstructive pulmonary disease Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Inferon administration to patients with chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009 Therapeutic responses in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 Bifunctional drugs for the treatment of asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2014; 44: 475-482 Year: 2014 Antioxidant properties of ambroxol in chronic obstructive pulmonary disease Source: Annual Congress 2010 - New insights into reactive oxygen species Year: 2010 Targeted therapy in eosinophilic chronic obstructive pulmonary disease Source: ERJ Open Res, 7 (2) 00437-2020; 10.1183/23120541.00437-2020 Year: 2021 Emerging drugs in chronic obstructive pulmonary disease Source: Annual Congress 2010 - Emerging drugs in COPD Year: 2010 Bronchodilators in chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=266 Year: 2006 Interleukin-18 production and pulmonary function in COPD Source: Eur Respir J 2008; 31: 287-297 Year: 2008 Systemic inflammation in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 5S-13S Year: 2003 Role of inhaled antioxidants in chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 717s Year: 2005 Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 624s Year: 2006 Fenspiride as complementary anti-inflammatory agent in therapy of patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD management Year: 2011 Safety and effectiveness of sputum induction in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 67s Year: 2001 IL-8 in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 364s Year: 2001 Rosuvastatin influence on inflammatory and anti-inflammatory cytokines in blood in patients with chronic obstructive pulmonary disease Source: International Congress 2017 – COPD management Year: 2017 Systemic effects of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 347-360 Year: 2003